# Microdialysis and Pharmacokinetic Study of TR-701

> **NCT00666601** · PHASE1 · COMPLETED · sponsor: **Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TR-700 (active moiety)
- **DRUG:** TR-701 (pro-drug)

## Key facts

- **NCT ID:** NCT00666601
- **Lead sponsor:** Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-04
- **Primary completion:** 2008-08-12
- **Final completion:** 2008-08-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666601, "Microdialysis and Pharmacokinetic Study of TR-701". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00666601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*